Tumor mutations may predict response to immunotherapy
Mismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes,
Read more
New study confirms EpCAM as promising target for cancer immunotherapy
Researchers have shown that cancer immunotherapy targeting the tumor biomarker epithelial cell adhesion molecule (EpCAM) is safe and non-toxic in
Read more
Study points to new strategy for boosting immunotherapy effectiveness in advanced colorectal cancer
Researchers at The University of Texas MD Anderson Cancer Center revealed the common oncogene KRAS as a possible explanation for
Read more
Using anti-cancer immunotherapy to fight HIV
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have shown that immunotherapy treatments against cancer could reduce the
Read more
Study suggests tumor mutational load may be useful metric to predict response to checkpoint-inhibitor immunotherapy
A large team of researchers affiliated with Sloan Kettering Cancer Center, Weill Cornell Medical Center and Columbia University Medical Center
Read more